Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125226642 | 12522664 | 2 | F | 20160618 | 20160815 | 20160701 | 20160829 | EXP | US-ACORDA-ACO_125623_2016 | ACORDA | 71.00 | YR | M | Y | 90.71000 | KG | 20160829 | CN | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125226642 | 12522664 | 1 | PS | AMPYRA | DALFAMPRIDINE | 1 | Oral | 10 MG, Q 12 HRS | U | U | 22250 | 10 | MG | TABLET | Q12H | ||||
| 125226642 | 12522664 | 2 | SS | AMPYRA | DALFAMPRIDINE | 1 | U | U | 22250 | TABLET | |||||||||
| 125226642 | 12522664 | 3 | C | AVONEX | INTERFERON BETA-1A | 1 | U | 0 | |||||||||||
| 125226642 | 12522664 | 4 | C | COPAXONE | GLATIRAMER ACETATE | 1 | U | 0 | |||||||||||
| 125226642 | 12522664 | 5 | C | BETASERON | INTERFERON BETA-1B | 1 | U | 0 | |||||||||||
| 125226642 | 12522664 | 6 | C | IMURAN | AZATHIOPRINE | 1 | U | 0 | |||||||||||
| 125226642 | 12522664 | 7 | C | METHOTREXATE. | METHOTREXATE | 1 | UNK | U | 0 | ||||||||||
| 125226642 | 12522664 | 8 | C | Amantadine | AMANTADINE | 1 | Oral | 100 MG, 1 CAP 2XDAY | U | 0 | 100 | MG | CAPSULE | BID | |||||
| 125226642 | 12522664 | 9 | C | OXYBUTYNIN CHLORIDE. | OXYBUTYNIN CHLORIDE | 1 | U | 0 | |||||||||||
| 125226642 | 12522664 | 10 | C | TECFIDERA | DIMETHYL FUMARATE | 1 | Oral | 50 MG, BID | U | 0 | 50 | MG | BID | ||||||
| 125226642 | 12522664 | 11 | C | TECFIDERA | DIMETHYL FUMARATE | 1 | 240 MG, BID | U | 0 | 240 | MG | BID | |||||||
| 125226642 | 12522664 | 12 | C | ECOTRIN | ASPIRIN | 1 | Oral | 81 MG, 2X/WK | U | 0 | 81 | MG | TABLET | BIW | |||||
| 125226642 | 12522664 | 13 | C | Atorvastatin | ATORVASTATIN | 1 | Oral | 20 MG, HS | U | 0 | 20 | MG | TABLET | QD | |||||
| 125226642 | 12522664 | 14 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Oral | 75 MG, QD | U | 0 | 75 | MG | TABLET | QD | |||||
| 125226642 | 12522664 | 15 | C | LOTRISONE | BETAMETHASONE DIPROPIONATECLOTRIMAZOLE | 1 | Cutaneous | 1% - 0.05%, BID | U | 0 | 1 | PCT | LOTION (EXCEPT LOTION FOR EYE) | BID | |||||
| 125226642 | 12522664 | 16 | C | FLONASE | FLUTICASONE PROPIONATE | 1 | Nasal | 50 ?G, QD | U | 0 | 50 | UG | SPRAY (EXCEPT INHALATION) | QD | |||||
| 125226642 | 12522664 | 17 | C | LASIX | FUROSEMIDE | 1 | Oral | 20 MG, BID | U | 0 | 20 | MG | TABLET | BID | |||||
| 125226642 | 12522664 | 18 | C | GLUCOPHAGE | METFORMIN HYDROCHLORIDE | 1 | Oral | 500 MG, BID | U | 0 | 500 | MG | TABLET | BID | |||||
| 125226642 | 12522664 | 19 | C | TOPROL XL | METOPROLOL SUCCINATE | 1 | Oral | 25 MG, QD | U | 0 | 25 | MG | TABLET | QD | |||||
| 125226642 | 12522664 | 20 | C | NITROSTAT | NITROGLYCERIN | 1 | Sublingual | 0.4 MG, PRN | U | 0 | .4 | MG | TABLET | ||||||
| 125226642 | 12522664 | 21 | C | O2 | 2 | UNK, HS | U | 0 | QD | ||||||||||
| 125226642 | 12522664 | 22 | C | DITROPAN | OXYBUTYNIN CHLORIDE | 1 | Oral | 5 MG, BID | U | 0 | 5 | MG | TABLET | BID | |||||
| 125226642 | 12522664 | 23 | C | Tadalafil | TADALAFIL | 1 | Oral | 20 MG, QD | U | 0 | 20 | MG | TABLET | QD | |||||
| 125226642 | 12522664 | 24 | C | KENALOG | TRIAMCINOLONE ACETONIDE | 1 | Cutaneous | 0.025 %, PRN | U | 0 | .025 | PCT | CREAM |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125226642 | 12522664 | 1 | Multiple sclerosis |
| 125226642 | 12522664 | 2 | Mobility decreased |
| 125226642 | 12522664 | 3 | Product used for unknown indication |
| 125226642 | 12522664 | 4 | Product used for unknown indication |
| 125226642 | 12522664 | 5 | Product used for unknown indication |
| 125226642 | 12522664 | 6 | Product used for unknown indication |
| 125226642 | 12522664 | 7 | Product used for unknown indication |
| 125226642 | 12522664 | 8 | Fatigue |
| 125226642 | 12522664 | 9 | Hypertonic bladder |
| 125226642 | 12522664 | 10 | Product used for unknown indication |
| 125226642 | 12522664 | 13 | Product used for unknown indication |
| 125226642 | 12522664 | 14 | Product used for unknown indication |
| 125226642 | 12522664 | 15 | Product used for unknown indication |
| 125226642 | 12522664 | 16 | Product used for unknown indication |
| 125226642 | 12522664 | 17 | Product used for unknown indication |
| 125226642 | 12522664 | 18 | Product used for unknown indication |
| 125226642 | 12522664 | 19 | Product used for unknown indication |
| 125226642 | 12522664 | 20 | Chest pain |
| 125226642 | 12522664 | 21 | Product used for unknown indication |
| 125226642 | 12522664 | 22 | Product used for unknown indication |
| 125226642 | 12522664 | 23 | Product used for unknown indication |
| 125226642 | 12522664 | 24 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125226642 | 12522664 | DE |
| 125226642 | 12522664 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125226642 | 12522664 | Cardio-respiratory arrest | |
| 125226642 | 12522664 | Ejection fraction decreased | |
| 125226642 | 12522664 | Off label use | |
| 125226642 | 12522664 | Respiratory distress |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125226642 | 12522664 | 1 | 20150914 | 0 | ||
| 125226642 | 12522664 | 7 | 2014 | 0 | ||
| 125226642 | 12522664 | 10 | 2015 | 0 | ||
| 125226642 | 12522664 | 11 | 201509 | 0 |